Does pharmacogenomic testing meaningfully improve antidepressant treatment outcomes when looking only at patients taking phase I hepatically metabolized drugs? A little

Joseph F. Goldberg

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations
Original languageEnglish
JournalJournal of Clinical Psychiatry
Volume80
Issue number6
DOIs
StatePublished - 2019

Cite this